AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2220647 — intervention group
Group type: COMPARATOR
Intervention: Nonpharmacologic treatment only
Number of subjects: 0
Study 93353 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (1.0 up to 1.5 g/day)
Number of subjects: 65
Study 93353 — intervention group
Group type: COMPARATOR
Intervention: Metizol (thiamazol) 60 mg/day
Number of subjects: 65
Study 93353 — intervention group
Group type: COMPARATOR
Intervention: Combined therapy with lithium and metizol
Number of subjects: 65
Study 6979347 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprivan alone
Number of subjects: 80
Study 6979347 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprivan and fentanyl
Number of subjects: 80
Study 6979347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl with diprivan
Number of subjects: 80
Study 6979347 — intervention group
Group type: COMPARATOR
Intervention: Propanidid and fentanyl
Number of subjects: 80
Study 6979347 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone and halothane
Number of subjects: 80
Study 30866886 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Traditional Style
Number of subjects: 140
Study 30866886 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Need-Supportive Style
Number of subjects: 140
Study 30866886 — intervention group
Group type: EXPERIMENTAL
Intervention: Theatre condition
Number of subjects: 140
Study 30866886 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control
Number of subjects: 140
Study 30297017 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D Portion Size Estimation Aids (PSEAs)
Number of subjects: 37
Study 30297017 — intervention group
Group type: COMPARATOR
Intervention: 3D Portion Size Estimation Aids (PSEAs)
Number of subjects: 37
Study 27272518 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-Phototherapy (large cluster probe, 33 diodes)
Number of subjects: 10
Study 27272518 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-Phototherapy (small cluster probe, 9 diodes)
Number of subjects: 10
Study 27272518 — intervention group
Group type: COMPARATOR
Intervention: LC-Placebo (large cluster probe, 33 diodes)
Number of subjects: 10
Study 27272518 — intervention group
Group type: COMPARATOR
Intervention: SC-Placebo (small cluster probe, 9 diodes)
Number of subjects: 10
Study 27272518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LC and SC Phototherapy
Number of subjects: 10
Study 27272518 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions tested (LC, SC, LC-placebo, SC-placebo)
Number of subjects: 10
Study 24388977 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast gamma activity (80-140 Hz) in the septal or posterior region of the hippocampus (bilaterally)
Number of subjects: 24
Study 24388977 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast gamma activity (80-140 Hz)
Number of subjects: 24
Study 23241439 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib Conventional Continuation Strategy (CCS)
Number of subjects: 0
Study 23241439 — intervention group
Group type: COMPARATOR
Intervention: Drug Free Interval Strategy (DFIS)
Number of subjects: 0
Study 20360291 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomographic coronary artery calcium assessment (CT CAC)
Number of subjects: 263
Study 17377504 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (0.05 mg/kg/day)
Number of subjects: 48
Study 17377504 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 15789598 — intervention group
Group type: EXPERIMENTAL
Intervention: Pearson's correlation
Number of subjects: 318
Study 15789598 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosine coefficient
Number of subjects: 318
Study 15789598 — intervention group
Group type: EXPERIMENTAL
Intervention: Goodman and Kruskal's Gamma coefficient
Number of subjects: 318
Study 15789598 — intervention group
Group type: COMPARATOR
Intervention: Other nine similarity measures
Number of subjects: 318
Study 11886906 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nail (Proximal Femoral Nail)
Number of subjects: 39
Study 11886906 — intervention group
Group type: COMPARATOR
Intervention: 95 fixed‐angle screw‐plate (Dynamic Condylar Screw)
Number of subjects: 39
Study 9841603 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton‐pump inhibitor (omeprazole or lansoprazole), amoxicillin, and either clarithromycin or ecabet sodium
Number of subjects: 35
Study 9841603 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 35
Study 7621685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesigyna
Number of subjects: 5680
Study 7621685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 5680
Study 7621685 — intervention group
Group type: EXPERIMENTAL
Intervention: Injectable No. 1
Number of subjects: 5680
Study 2642284 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional evaluation by an interdisciplinary geriatric consultation team
Number of subjects: 178
Study 2642284 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 178
Study 351716 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel administered extraamniotically
Number of subjects: 20
Study 351716 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (i.v. oxytocin, 20% NaCl solution, Premarin, balloon catheter, Rivanol)
Number of subjects: 20
Study 30264293 — intervention group
Group type: EXPERIMENTAL
Intervention: E6201, an intravenous MEK1 inhibitor
Number of subjects: 1
Study 28603112 — intervention group
Group type: EXPERIMENTAL
Intervention: Safoof akseer e jigar (test drug)
Number of subjects: 87
Study 28603112 — intervention group
Group type: COMPARATOR
Intervention: Interferon Alpha (control therapy)
Number of subjects: 87
Study 25524478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab with PX-866 (8 mg p.o. daily)
Number of subjects: 83
Study 25524478 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab without PX-866
Number of subjects: 83
Study 24188184 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal jugular veins (IJVs) in MS patients with CCSVI during head rotation
Number of subjects: 313
Study 24188184 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal jugular veins (IJVs) in MS patients with CCSVI
Number of subjects: 313
Study 24188184 — intervention group
Group type: EXPERIMENTAL
Intervention: CCSVI scores in MS patients
Number of subjects: 313
Study 21220064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for PTSD treatment
Number of subjects: 66
Study 21220064 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 66
Study 19736332 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyretic agents (rectal diclofenac followed by oral ibuprofen or acetaminophen)
Number of subjects: 231
Study 19736332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study 17577104 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelnidipine 8 to 16 mg (average 14.5 mg)
Number of subjects: 47
Study 17577104 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 2.5 to 7.5 mg (average 4.9 mg)
Number of subjects: 47
Study 15025886 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic vital force ratings
Number of subjects: 62
Study 10783649 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (24 micrograms)
Number of subjects: 20
Study 10783649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9115054 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment initiation
Number of subjects: 0
Study 9115054 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment discontinuation
Number of subjects: 0
Study 8416468 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential fatty acids
Number of subjects: 27
Study 8416468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 3086023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutrition with hypertonic glucose at energy intakes of 6650 to 17,100 kJ/day
Number of subjects: 0
Study 3086023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutrition with hypertonic glucose
Number of subjects: 0
Study 30549292 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 421
Study 30549292 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 421
Study 30549292 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic Acid
Number of subjects: 421
Study 30549292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study 29165106 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive VDU lenses (VDU group)
Number of subjects: 35
Study 29165106 — intervention group
Group type: COMPARATOR
Intervention: Progressive lenses (P group)
Number of subjects: 35
Study 26052959 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) during CPB
Number of subjects: 50
Study 26052959 — intervention group
Group type: COMPARATOR
Intervention: No mechanical ventilation (MV) during CPB
Number of subjects: 50
Study 23952947 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 52
Study 23952947 — intervention group
Group type: COMPARATOR
Intervention: Other antihypertensive drugs
Number of subjects: 52
Study 21371369 — intervention group
Group type: EXPERIMENTAL
Intervention: Evoked response audiometry
Number of subjects: 25
Study 21371369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure tone audiometry
Number of subjects: 25
Study 21371369 — intervention group
Group type: COMPARATOR
Intervention: Scrub typhus
Number of subjects: 25
Study 19695405 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic enoxaparin 60 mg SC
Number of subjects: 22
Study 19695405 — intervention group
Group type: COMPARATOR
Intervention: Branded enoxaparin 60 mg SC
Number of subjects: 22
Study 16897979 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 + biweekly docetaxel (DOC) combination therapy
Number of subjects: 33
Study 12768557 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized uterine artery pulsatility index (PI)
Number of subjects: 126
Study 12768557 — intervention group
Group type: COMPARATOR
Intervention: Non-normalized uterine artery PI
Number of subjects: 126
Study 12768557 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized uterine artery PI
Number of subjects: 126
Study 10757544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (39.5% calories as fat) without red wine for 30 days
Number of subjects: 11
Study 10757544 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (39.5% calories as fat) with red wine (240 mL/d) for 30 days
Number of subjects: 11
Study 10757544 — intervention group
Group type: COMPARATOR
Intervention: Control diet (27% calories as fat) without red wine for 30 days
Number of subjects: 11
Study 10757544 — intervention group
Group type: COMPARATOR
Intervention: Control diet (27% calories as fat) with red wine (240 mL/d) for 30 days
Number of subjects: 11
Study 9015522 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent anti-B. atrox antivenom (group A)
Number of subjects: 39
Study 9015522 — intervention group
Group type: COMPARATOR
Intervention: Polyvalent (Crotalinae) antivenom (group B)
Number of subjects: 39
Study 9015522 — intervention group
Group type: EXPERIMENTAL
Intervention: Both antivenoms
Number of subjects: 39
Study 1633702 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporin (CS) formulation (10%)
Number of subjects: 0
Study 1633702 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo formulation
Number of subjects: 0
Study 1633702 — intervention group
Group type: COMPARATOR
Intervention: Flumethasone pivalate (FP) formulation (0.02%)
Number of subjects: 0
Study 1633702 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 6649755 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 22
Study 6649755 — intervention group
Group type: COMPARATOR
Intervention: Diuretics
Number of subjects: 22
Study 30771825 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapularis tenotomy (ST)
Number of subjects: 60
Study 30771825 — intervention group
Group type: COMPARATOR
Intervention: Lesser tuberosity osteotomy (LTO)
Number of subjects: 60
Study 27194263 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant Force Feedback (CFF)
Number of subjects: 51
Study 27194263 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandwidth Force Feedback (BFF)
Number of subjects: 51
Study 27194263 — intervention group
Group type: EXPERIMENTAL
Intervention: Fade-in Force Feedback
Number of subjects: 51
Study 27194263 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CFF, BFF, Fade-in)
Number of subjects: 51
Study 26840505 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthohumol drink (12 mg XN/P/day)
Number of subjects: 22
Study 26840505 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure Xanthohumol in a follow-up study (n = 10)
Number of subjects: 22
Study 24751788 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 1 μg/kg/hr
Number of subjects: 219
Study 24751788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 22952182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (600 μg retinyl palmitate/d)
Number of subjects: 62
Study 22952182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (300 μg retinyl palmitate/d)
Number of subjects: 62
Study 22952182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A + zinc (10 or 20 mg zinc sulfate/d)
Number of subjects: 62
Study 22952182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 20212335 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate (AS) + Sulphadoxine-Pyrimethamine (SP)
Number of subjects: 160
Study 20212335 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate (AS) + Amodiaquine (AQ)
Number of subjects: 160
Study 17285405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous-based (IV) anesthesia with modified neurolept anesthesia (droperidol 0.2 mg/kg and pentazocine 0.15-0.3 mg/kg) and postoperative intravenous infusion of buprenorphine (20 µg/ml) via PCA pump.
Number of subjects: 30
Study 17285405 — intervention group
Group type: COMPARATOR
Intervention: Epidural-based (EPI) anesthesia with combined epidural analgesia and general anesthesia (sevoflurane and nitrous oxide) followed by epidural infusion of 0.125% bupivacaine and 5 µg/ml buprenorphine.
Number of subjects: 30
Study 15644018 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Laryngeal Mask Airway (CLMA)
Number of subjects: 42
Study 15644018 — intervention group
Group type: EXPERIMENTAL
Intervention: Portex Soft Seal Laryngeal Mask Airway (PLMA)
Number of subjects: 42
Study 15644018 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 42
Study 11851643 — intervention group
Group type: EXPERIMENTAL
Intervention: L-N(G)-monomethyl arginine (LNMMA) at doses of 0.1, 0.3, 1.0 and 3.0 mg kg‐1 min‐1
Number of subjects: 8
Study 11851643 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 8
Study 10201745 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver
Number of subjects: 87
Study 10201745 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver with augmented head rotations
Number of subjects: 87
Study 10201745 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Semont maneuver
Number of subjects: 87
Study 10201745 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 87
Study 7775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 3 mg/kg
Number of subjects: 8
Study 7775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 6 mg/kg
Number of subjects: 8
Study 7775331 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 9 mg/kg
Number of subjects: 8
Study 7775331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1320279 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 65
Study 1320279 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral stress management (CBSM)
Number of subjects: 65
Study 1320279 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only controls (HIV-1 seropositive and seronegative)
Number of subjects: 65
Study 6474386 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively ionised air (5‐10 X 10(5) ions/cm)
Number of subjects: 12
Study 6474386 — intervention group
Group type: COMPARATOR
Intervention: Control air (not ionised)
Number of subjects: 12
Study 30921490 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of plant-derived pharmaceutical formulation of highly purified cannabidiol (CBD) in oral solution (Epidiolex, 100 mg/mL)
Number of subjects: 38
Study 30921490 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of CBD
Number of subjects: 38
Study 30136062 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Program to Improve Home Visitor Communication
Number of subjects: 0
Study 25667244 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal synchronized intermittent positive pressure ventilation (NSIPPV)
Number of subjects: 124
Study 25667244 — intervention group
Group type: COMPARATOR
Intervention: Bilevel continuous positive airway pressure (BiPAP)
Number of subjects: 124
Study 23810328 — intervention group
Group type: EXPERIMENTAL
Intervention: Penthrox
Number of subjects: 251
Study 21784820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 59
Study 21784820 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 59
Study 19778983 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 4130
Study 19778983 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-iron
Number of subjects: 4130
Study 19778983 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid-iron-zinc
Number of subjects: 4130
Study 19778983 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients
Number of subjects: 4130
Study 19778983 — intervention group
Group type: COMPARATOR
Intervention: Controls (vitamin A only)
Number of subjects: 4130
Study 19778983 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal iron-folic acid supplementation
Number of subjects: 4130
Study 16933434 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjoint group treatment
Number of subjects: 0
Study 16933434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-specific group treatment
Number of subjects: 0
Study 15120711 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (120 microg/day p.o.)
Number of subjects: 44
Study 15120711 — intervention group
Group type: COMPARATOR
Intervention: Control (no beraprost sodium)
Number of subjects: 44
Study 11402826 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dorzolamide eye drops, 3 times daily for a mean follow up of 9 months
Number of subjects: 28
Study 9364107 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo techniques training (N=29)
Number of subjects: 57
Study 9364107 — intervention group
Group type: COMPARATOR
Intervention: Classroom techniques training (N=13)
Number of subjects: 57
Study 9364107 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group (N=15)
Number of subjects: 57
Study 1414289 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary argon laser trabeculoplasty
Number of subjects: 82
Study 1414289 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine
Number of subjects: 82
Study 4035650 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin III (AT III) substitution
Number of subjects: 51
Study 4035650 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 51
Study 4035650 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AT III and Heparin
Number of subjects: 51
Study 30758329 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg CBD
Number of subjects: 34
Study 30758329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 29420749 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation group (Prosure®)
Number of subjects: 0
Study 29420749 — intervention group
Group type: COMPARATOR
Intervention: Non‐intervention group
Number of subjects: 0
Study 26647415 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes group visits with individualized sessions and diabetes self-management education
Number of subjects: 80
Study 26647415 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 80
Study 24643901 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox-driven bronchodilation therapy
Number of subjects: 132
Study 24643901 — intervention group
Group type: COMPARATOR
Intervention: Air-driven bronchodilation therapy
Number of subjects: 132
Study 23257487 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermo-mechanical cycling (TMC)
Number of subjects: 100
Study 23257487 — intervention group
Group type: COMPARATOR
Intervention: Water storage at 37C for 24 hours (Control)
Number of subjects: 100
Study 19815809 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 288
Study 19815809 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 288
Study 18808627 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile touch intervention (n = 21)
Number of subjects: 44
Study 18808627 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group, n = 23)
Number of subjects: 44
Study 18808627 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 44
Study 16160598 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine (600 mg orally twice daily on the day before and the day of contrast administration)
Number of subjects: 50
Study 16160598 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acetylcysteine, saline 0.9% intravenously at 1 mL/kg/h for 12 hours before and after contrast administration)
Number of subjects: 50
Study 16160598 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum creatinine >2.5 mg/dL
Number of subjects: 50
Study 16160598 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum creatinine <2.5 mg/dL
Number of subjects: 50